跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,654 条关于
“NTX-253”
全部
4,654
临床试验
2,851
药物
1,283
机构
18
资讯
502
8个月前
Neurosterix Initiates Phase 1 Trial of NTX-253, Novel M4 Receptor Modulator for Schizophrenia Treatment
2年前
Neuraptive's NTX-001 Receives FDA Breakthrough Therapy Designation for Peripheral Nerve Injury
2个月前
Epigenetic Therapy NTX-301 Activates Hippo Pathway to Overcome Treatment-Resistant AML
11个月前
Neuraptive Therapeutics Initiates Phase 3 Trial for NTX-001 in Traumatic Peripheral Nerve Injuries
7个月前
NexEos Bio Receives FDA Clearance for Phase II/III Trial of NTX-1024 in Rare Eye Disease
25天前
AGC and Neusignal Therapeutics Collaborate to Advance NTX-083, an Oral Alzheimer's Disease Candidate, Toward U.S. Clinical Trials
3个月前
Nectin Therapeutics' First-in-Class Anti-CD155 Antibody NTX1088 Shows Promise in Phase 1 Combo Trial at ASCO 2026
2年前
Kymera Therapeutics Advances Clinical Programs with Focus on IRAK4, STAT6, and Oncology Assets
去年
NTxBio to Establish $31M Biomanufacturing Facility in Plano, Texas Creating 170 Jobs
12个月前
Nuclide Therapeutics Secures £5M to Advance ALDH1A1-Targeted Radiotheranostics for Therapy-Resistant Cancers
第 1 页,共 51 页
上一页
下一页